Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-05-31T13:16:51.293Z Has data issue: false hasContentIssue false

The development and validation of the Discrimination and Stigma Scale Ultra Short for People Living with Dementia (DISCUS-Dementia)

Published online by Cambridge University Press:  31 August 2023

Jem Bhatt
Affiliation:
UCL Unit for Stigma Research, Research Department of Clinical, Educational and Health Psychology, University College London, UK
Elaine Brohan
Affiliation:
Centre for Global Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK
Drew Blasco
Affiliation:
Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Michigan, USA; Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, USA; and Department of Social and Behavioral Health, School of Public Health, University of Nevada, Las Vegas, USA
Déborah Oliveira
Affiliation:
Faculty of Nursing, Universidad Andrés Bello, Campus Vina del Mar,Chile; and Millennium Institute for Care Research (MICARE), Santiago,Chile
Ioannis Bakolis
Affiliation:
Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK
Adelina Comas-Herrera
Affiliation:
Care Policy and Evaluation Centre, London School of Economics and Political Science, UK
Francesco D'Amico
Affiliation:
Care Policy and Evaluation Centre, London School of Economics and Political Science, UK
Nicolas Farina
Affiliation:
Centre for Dementia Studies, Brighton and Sussex Medical School, UK
Martin Knapp
Affiliation:
Care Policy and Evaluation Centre, London School of Economics and Political Science, UK
Madeleine Stevens
Affiliation:
Care Policy and Evaluation Centre, London School of Economics and Political Science, UK
Graham Thornicroft
Affiliation:
Centre for Global Mental Health and Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK
Emma Wilson
Affiliation:
ESRC Centre for Society and Mental Health, King's College London, UK
Maximilian Salcher-Konrad
Affiliation:
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Austrian National Public Health Institute (Gesundheit Österreich GmbH/GÖG), Austria
Lawrence H. Yang
Affiliation:
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
Sara Evans-Lacko*
Affiliation:
Care Policy and Evaluation Centre, London School of Economics and Political Science, UK
*
Correspondence: Sara Evans-Lacko. Email: s.evans-lacko@lse.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Background

The recent World Health Organization (WHO) blueprint for dementia research and Lancet Commission on ending stigma and discrimination in mental health has identified a gap around dementia-related measures of stigma and discrimination that can be used in different cultural, language and regional contexts.

Aims

We aimed to characterise experiences of discrimination, and report initial psychometric properties of a new tool to capture these experiences, among a global sample of people living with dementia.

Method

We analysed data from 704 people living with dementia who took part in a global survey from 33 different countries and territories. Psychometric properties were examined, including internal consistency and construct validity.

Results

A total of 83% of participants reported discrimination in one or more areas of life, and this was similar across WHO Regions. The exploratory factor analysis factor loadings and scree plot supported a unidimensional structure for the Discrimination and Stigma Scale Ultra Short for People Living with Dementia (DISCUS-Dementia). The instrument demonstrated excellent internal consistency, with most of the construct validity hypotheses being confirmed and qualitative responses demonstrating face validity.

Conclusions

Our analyses suggest that the DISCUS-Dementia performs well with a global sample of people living with dementia. This scale can be integrated into large-scale studies to understand factors associated with stigma and discrimination. It can also provide an opportunity for a structured discussion around stigma and discrimination experiences important to people living with dementia, as well as planning psychosocial services and initiatives to reduce stigma and discrimination.

Type
Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists

There are approximately 52.2 million people living with dementia globally, and it has been estimated that this number will increase to 150 million by 2050.Reference Nichols, Steinmetz, Vollset, Fukutaki, Chalek and Abd-Allah1 The global cost of dementia is approximately $1.3 trillion, which is estimated to increase to $2.8 trillion by 2030.Reference Wimo, Seeher, Cataldi, Cyhlarova, Dielemann and Frisell2 People living with dementia have to manage clinical symptoms and disability, but they also face stigma and discrimination, which can undermine life goals, reduce participation in meaningful activities and lower well-being and quality of life.3,Reference Thornicroft, Sunkel, Alikhon Aliev, Baker, Brohan and el Chammay4 Stigma can be conceptualised as comprising problems of knowledge (ignorance), attitudes (prejudice) and behaviour (discrimination).Reference Thornicroft, Sunkel, Alikhon Aliev, Baker, Brohan and el Chammay4 Discrimination is considered the behavioural enactment of ignorance and prejudice. The consequences of stigma are often described by people with mental health conditions as being worse than the condition itself.Reference Thornicroft, Sunkel, Alikhon Aliev, Baker, Brohan and el Chammay4 However, most research focuses on clinical and care experiences of dementia rather than social consequences, and is often conducted about or for people living with dementia, rather than with them.Reference Young, Lind, Orange and Savundranayagam5 Both qualitative and quantitative evidence on experiences of discrimination among people living with dementia is lacking.Reference Nguyen and Li6 This is particularly true in low- and middle-income countries (LMICs), where nearly 70% of people currently living with dementia reside.7

Previous dementia-related stigma research has mostly focused on quantifying stereotypes and prejudice toward people living with dementia from family members or the general public.Reference Nguyen and Li6,Reference Herrmann, Welter, Leverenz, Lerner, Udelson and Kanetsky8 Capturing such ‘public stigma’ has value, but is limited by relying on views of potential ‘stigmatisers’ rather than people living with dementia, potentially increasing social desirability bias and underestimating the scale of the problem. A further limitation is that studies investigating public stigma often omit the context in which stigmatisation occurred (e.g. hospital settings, social situations), as well as the consequence (e.g. excluded from social gatherings). Some research has explored the experience of stigma and discrimination among people living with dementia and their care partners by using qualitative methods, including participants from LMICs,Reference Hurzuk, Farina, Pattabiraman, Ramasamy, Alladi and Rajagopalan9Reference Jacobs, Schneider, Farina, du Toit and Evans-Lacko12 and a few studies have quantitatively assessed self-reported experiences of people living with dementia by using the Stigma Impact Scale (SIS) and Stigma Experience Scale.Reference Burgener and Berger13,Reference Burgener, Buckwalter, Perkhounkova and Liu14 These measures, however, demonstrate low reliability for people living with dementia, given they were not designed for this population and were validated among small samples in Western high-income countries. Additionally, these measures focus on perceived stigma (e.g. ‘I have worried’) rather than experiences of discrimination. A standardised tool to assess dementia-related stigma and discrimination across varying global contexts would be of great value. The Discrimination and Stigma Scale Ultra Short (DISCUS) is an existing tool that assesses the scope and context of experienced discrimination among people with mental health conditions, and has previously demonstrated excellent reliability and factor structure in large global samples.Reference Thornicroft, Brohan, Rose, Sartorius and Leese15,Reference Brohan, Thornicroft, Rüsch, Lasalvia, Campbell and Yalçlnkaya-Alkar16 We sought to adapt the DISCUS for people living with dementia, to address the aforementioned research gaps and test its psychometric properties. We refer to the adapted instrument as the Discrimination and Stigma Scale Ultra Short for People Living with Dementia (DISCUS-Dementia).

Overarching aim

We aimed to characterise the experiences and frequency of discrimination among a global sample of people living with dementia, as well as describe the psychometric properties of a new tool to capture these experiences.

Research objectives

The research objectives for this study were to adapt the DISCUS for use among people living with dementia and describe the measure and its psychometric properties across and within World Health Organization (WHO) regions; to describe and compare frequency of endorsement of discrimination by life domains among people living with dementia, assessed using the DISCUS-Dementia, overall and by WHO Region; and to describe examples of discrimination reported by people living with dementia according to different life domains.

Method

Study design

Data were gathered as part of a large, cross-sectional global survey for the World Alzheimer Report 2019, which surveyed the general public, healthcare professionals, caregivers and people living with dementia.3 Here, we focus on data from participants who self-identified as living with dementia.

Participants

We partnered with Alzheimer's Disease International (ADI) to recruit participants. We ran webinars (in English and Spanish) for members of ADI organisations to discuss recruitment strategies. Participants were also recruited from various online platforms: dementia discussion boards, social media, the ADI website, mailing lists of national Alzheimer's or similar associations, social care organisations, support groups and other third-sector or faith-based organisations. Written informed consent was obtained from all patients.

To achieve good representation, outreach by health and community workers in rural regions and places without internet access was done by hardcopy forms; ADI member organisations facilitating internet access at their own offices and events; and use of Mobenzi for Windows (Mobenzi Technologies, Cape Town, South Africa; see https://www.engineeringforchange.org/solutions/product/mobenzi/), a tool supporting offline data collection.

People living with dementia (n = 742) from 33 countries responded to this survey (Supplementary Table 2 available at https://doi.org/10.1192/bjo.2023.551). Given the limited amount of respondents from the African, Eastern Mediterranean and South-East Asia Regions, our psychometric study sample included 704 people living with dementia from three WHO Regions – the European Region, Region of the Americas and Western Pacific Region – representing 33 countries and/or territories worldwide. Participant sociodemographic characteristics, overall and by WHO Region, are presented in Supplementary Table 2. Most participants completed the survey alone (86.2%), whereas others required support (5.3%) and 8.5% did not respond to this question.

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. As we analysed fully anonymised data collected by an outside organisation (ADI), all procedures involving human patients were approved by the London School of Economics and Political Science self-certification process (reference: CPEC-LSE-2019-SE-06).

Development, translation and final version of the DISCUS-Dementia

We adapted the original DISCUS, globally validated for people with mental illness, which collects quantitative information on experience of discrimination across 11 life areas.Reference Brohan, Thornicroft, Rüsch, Lasalvia, Campbell and Yalçlnkaya-Alkar16 Those who report discrimination are then asked to provide qualitative examples. As the original measure focused on mental illness, we first reviewed DISCUS items to ensure domains were relevant and sufficient for people living with dementia. We identified studies from a recent systematic review that captured the global literature on stigma and dementia, and extracted constructs from primary studies included in it.Reference Nguyen and Li6 We then systematically mapped identified constructs and compared them with items included in the DISCUS, to identify overlap and potential gaps. We further validated constructs with stakeholders (including people living with dementia, experts in stigma and dementia-related research and representatives from ADI associations around the world, to include perspectives from a range of cultures and contexts). As a result of this process, three items were added, to form the DISCUS-Dementia (Supplementary Table 1). To further improve accessibility, we translated the survey into 32 languages. All translations adhered to WHO guidelines17 and were mostly done by staff of ADI member organisations.

The DISCUS-Dementia comprised 14 items covering domains of everyday life, including privacy, personal safety, responsibilities and rights, social, familial and intimate relationships, housing and healthcare. Participants rated items on a four-point scale (0 being ‘not applicable’, 1 being ‘a little’, 2 being ‘moderately’ and 3 being ‘a lot’). Each item had a free-text option to include examples of discrimination.

Additional measures

Warwick-Edinburgh Mental Well-Being Scale

The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) is a 14-item scale that assesses mental well-being.Reference Tennant, Hiller, Fishwick, Platt, Joseph and Weich18 Although not dementia specific, it has been used to assess mental well-being among people living with dementia in several studies,Reference Clarke, Woods, Moniz-Cook, Mountain, Øksnebjerg and Chattat19 and has been extensively validated in adult populations with good psychometric properties (e.g. internal consistency Cronbach's alpha of 0.91–0.94; test–retest reliability intraclass correlation coefficient of 0.83).Reference Marmara, Zarate, Vassallo, Patten and Stavropoulos20 Scores range from 14 to 70, with higher scores indicating greater positive mental well-being.

Dementia Quality of Life Instrument

The Dementia Quality of Life Instrument (DQoL) is a disease-specific measure of quality of life, designed to be self-completed by persons with mild-to-moderate dementia.Reference Brod, Stewart, Sands and Walton21 Previous research in three European countries found the DQoL to be negatively associated with stigma impact (assessed by the SIS).Reference Lion, Szcześniak, Bulińska, Evans, Evans and Saibene22 Based on feedback from our advisory panel of stigma experts and people with lived experience, we included three of the five subscales that were significantly associated with the SIS: self-esteem, negative affect and feelings of belonging.Reference Lion, Szcześniak, Bulińska, Evans, Evans and Saibene22 Previous research suggests these subscales have demonstrated moderate-to-good internal consistency (Cronbach's alpha of 0.67–0.89) and test–retest reliability (intraclass correlation coefficient of 0.64–0.74).Reference Brod, Stewart, Sands and Walton21 Higher scores indicate more positive quality of life.

SIS

The SIS is a 21-item measure rated on a Likert scale from 1 to 4, with the addition of 0 for items that participants felt were ‘not applicable’. As a result of the development and adaptation process and stakeholder feedback,3 one item was deemed irrelevant and removed (item 21: ‘Changes in my appearance have affected my social life’). In this case, the total score ranged from 20 to 92, with higher scores indicating greater perceived stigma impact. In a study of people living with dementia, it showed good internal consistency (Cronbach's alpha of 0.906) and test–retest reliability (intraclass correlation coefficient of 0.774).Reference Bhatt, Stoner, Scior and Charlesworth23

Sociodemographic characteristics

To characterise our sample, we collected information on gender, age, highest level of education, country/territory of residence, urbanicity and employment status.

Data analysis

Survey weights were developed to match characteristics of the sample to the nationally representative characteristics in each country, according to gender, age and education. Responses with weights >20 were excluded (<0.2% of the sample) because of non-representativeness.

Face validity and concept checking

Qualitative responses were assessed for respondent understanding (face validity) based on whether the response was relevant to the item's focus (e.g. ‘Have you been treated unfairly in housing?’). A simple coding scheme was applied to indicate the relevance of each response (yes/no) and the reason for any irrelevance. Initially, 10% of responses were coded independently by three researchers (J.B., D.B. and D.O.). Discrepancies were discussed until agreement was reached. Remaining responses were coded individually. Coders met to discuss responses that were unclear, and to reach consensus. Exemplar responses for each question were identified and included in Table 1. All qualitative examples provided by respondents were translated into English before any data were reviewed and checked for accuracy and consistency by the research team.

Table 1 DISCUS-Dementia face validity and exemplar quotes

DISC-Dementia, Discrimination and Stigma Scale Ultra Short for People Living with Dementia.

a. Number of text responses recorded for DISC-Dementia item.

b. Percentage of qualitative responses that were coded by authors as satisfactorily reflecting participant understanding of the item.

Psychometric analysis

Summary statistics were calculated for all measures. DISCUS-Dementia scores were calculated for each item and for the total scale, and then summarised for each WHO Region with sufficient sample size. We excluded participants from the African, South-East Asia and Eastern Mediterranean Regions because of low sample size (Supplementary Table 2). For reference, data from participants in these regions are described in Supplementary Table 2. DISCUS-Dementia item means were also calculated (range 0–3; 0 being ‘not at all’, 1 being ‘a little’, 2 being ‘moderately’ and 3 being ‘a lot’). ‘Not applicable’ answers were recoded as ‘0’ for analyses with the total sample, as well as by each included WHO Region.

Psychometric analysis focused on (a) examining scaling assumptions in a dementia population, (b) evaluating scale reliability and (c) evaluating construct validity.

When more than two item scores were missing, the mean score was not calculated (in 33 out of 704 cases); otherwise, subscale and total scores were generated in keeping with scoring instructions for each instrument. Analysis was performed with SPSS version 26 for Windows and Stata version 16 for Windows.

DISCUS-Dementia scaling assumptions

Exploratory factor analysis (EFA) was used to test the assumption of unidimensionality, which has been established for other DISCUS populations (e.g. people with depression or schizophrenia).Reference Brohan, Thornicroft, Rüsch, Lasalvia, Campbell and Yalçlnkaya-Alkar16,Reference Bakolis, Thornicroft, Vitoratou, Rüsch, Bonetto and Lasalvia24 Varimax rotation was applied to improve interpretability of factors obtained. Eigenvalues, scree plot and proportion of variance explained by each factor were used to evaluate factor structure. Each item having a loading of ≥0.4 on one factor, with a lower loading on other factors, was considered as a threshold for unidimensionality.Reference Cappelleri, Zou, Bushmakin, Alvir, Alemayehu and Symonds25

As a sensitivity analysis, EFA was also run separately for each region.

Reliability and validity

Reliability of the DISCUS-Dementia was assessed with Cronbach's alpha, with a criterion of α ≥ 0.70 indicative of appropriate internal consistency; α > 0.90 were also flagged, as this may indicate item redundancy. Two aspects of construct validity were assessed: known-groups method and convergent validity.Reference Brohan, Thornicroft, Rüsch, Lasalvia, Campbell and Yalçlnkaya-Alkar16 The known-groups method assessed differences in scores between participants who differed on identified clinical variables. The criterion was considered met when significantly different DISCUS scores (defined as P<0.05) were obtained between sample subgroups. The following groups were considered: WEMWBS score (higher mental well-being (score of ≥42) versus lower mental well-being (score of ≤41)) and DQoL score (higher quality of life (median score of >2.25) versus lower quality of life (median score of ≤2.25)). In convergent validity analyses, it was hypothesised there would be moderate positive correlation (r = 0.30–0.49) between mean DISCUS-Dementia score and SIS.Reference Cohen26

As a sensitivity analysis, psychometric properties were analysed for the subgroup of individuals who required support to complete the survey. This subgroup was considered to reflect those who may experience greater impairment owing to dementia symptoms. Significance tests are not included for this analysis because of small sample size.

Results

Most DISCUS items demonstrated face validity, with almost all qualitative responses reflecting participants understood the item (≥85%), with the exception of one item (‘Have you experienced unfair treatment in your levels of privacy?’; 52.6%; see Table 1).

Psychometric properties of the DISCUS-Dementia

The EFA factor loading and scree plot supported a unidimensional structure (Table 2 and Supplementary Fig. 1). All items loaded most highly on the first factor, with loadings on the second factor lower in all cases (<0.3). The percent of total variance explained by the first factor was 52.4%, with an additional 7.4% explained with inclusion of a second factor. Sensitivity analysis suggested this model was also appropriate in each regional subsample, with 48.8% of variance explained by the first factor in the Region of the Americas, 55.1% in the European Region and 51.0% in the Western Pacific Region. The interpretability of each model was not improved by inclusion of a second factor.

Table 2 Exploratory factor analysis

Reliability of DISCUS-Dementia items and total score was satisfactorily established. Cronbach's alpha coefficient was excellent for all regions (α = 0.90–0.93), and only negligible increases (0.01) were noted in two of the three regions when an item was dropped (Table 3).

Table 3 Summary of psychometric properties of the DISCUS-Dementia by region

DISCUS-Dementia, Discrimination and Stigma Scale Ultra Short for People Living with Dementia; WEMWBS, Warwick-Edinburgh Mental Well-Being Scale; DQoL, Dementia Quality of Life Instrument; QoL, quality of life.

a. See Table 3 for results of exploratory factor analysis.

b. Spearman's rho was used for convergent validity analysis because of the non-normality of DISCUS-Dementia mean scores.

c. Wilcoxon rank-sum test was used to compare median scores for known-groups analysis because of the non-normality of DISCUS-Dementia mean scores.

*P < 0.001.

There was evidence of convergent validity in the total sample and in the Region of the Americas and Western Pacific Region, as moderate/high correlation was seen between mean DISCUS score and SIS. Convergent validity was not supported in the European Region. There was evidence of construct validity using the known-groups method in the total sample and in the Region of the Americas, European Region and Western Pacific Region, with a significant difference between groups seen for each hypothesised relationship (mental well-being and quality of life). There was initial evidence that the psychometric properties, including scaling assumptions, reliability and validity, were replicated in the subgroup of individuals who required support to complete the survey, with inter-item polychoric correlation (mean 0.57), internal consistency (α = 0.93), convergent validity (0.33), known-group method WEMWBS (0.14 higher mental well-being v. 0.45 lower mental well-being) and known-group method DQoL (0.33 higher quality of life v. 0.40 lower quality of life).

Prevalence of discrimination

Overall, results indicated that when examining discrimination by life domain across all three regions included in analysis, the most highly endorsed DISCUS-Dementia items (i.e. respondents choosing either ‘a little’, ‘moderately’ or ‘a lot’) were: ‘Do people do things for you that you could do yourself because they know you have dementia?’ (51.3%), ‘Because of your dementia have some people not taken your opinions seriously?’ (50.2%) and ‘Have you been told that you couldn't do something that you still thought you could do?’ (44.0%) (Table 4).

Table 4 Endorsement of unfair treatment among people living with dementia overall and by region

DISCUS-Dementia, Discrimination and Stigma Scale Ultra Short for People Living with Dementia.

The least commonly endorsed items were around privacy (13.5%), personal safety and security (13.3%) and housing (9.3%). When comparing prevalence of discrimination across WHO Regions, there was good alignment regarding the most and least commonly endorsed items. Overall, 82.8% of participants reported discrimination in one or more areas of life: 82.8% in the Region of the Americas, 85.0% in the European Region and 82.9% in the Western Pacific Region.

Discussion

This paper describes the development and psychometric validation of the DISCUS-Dementia, which can be used to assess the nature, type and degree of experiences of stigma and discrimination among people living with dementia. It addresses a gap flagged in the recent 2022 WHO blueprint for dementia research,27 for measures of stigma and discrimination that can be used in different cultural, language and regional contexts. Findings demonstrate strong psychometric properties and characterise experiences of stigma and discrimination of people living with dementia from three global regions. Qualitative responses, describing examples of discrimination, provide further support for comprehensibility and face validity among people living with dementia.

The DISCUS-Dementia demonstrated excellent reliability across three WHO Regions, and performed similarly or better compared with the original DISCUS. Construct validity was demonstrated with known-groups validity, established using groups defined by quality of life and well-being in each region. Convergent validity was demonstrated in all regions apart from the European Region. In the European Region, stigma impact scores were, on average, similar to other regions; however, DISCUS scores were lower, on average, than in other regions. All other proposed thresholds for psychometric analysis were met in the European Region, and all thresholds across the other regions were met.

The DISCUS-Dementia addresses previous research gaps, providing an alternative to existing scales such as the SIS and Stigma Experience Scale, which focus on perceived stigma rather than experiences of stigma and discrimination, with validation in much smaller samples.Reference Burgener and Berger13,Reference Burgener, Buckwalter, Perkhounkova and Liu14 Moreover, adaptation of the DISCUS-Dementia was undertaken in consultation with experts with lived experience and stigma research and practice experts from diverse settings, to consider experiences, domains and language that may be particularly relevant for people living with dementia. In contrast to the SIS, which had varying internal consistency for subscales ranging from 0.58 to 0.82, the DISCUS-Dementia demonstrated excellent internal consistency, with alpha values ranging from 0.90 to 0.92 across three WHO Regions. The adaptation process for the DISCUS-Dementia, which included tailoring an existing measure so that it aligned with what is most valued by or ‘what matters most’ for the target population, is recommended to improve construct validity.Reference Yang, Thornicroft, Alvarado, Vega and Link28

Frequency and type of discrimination reported across regions

Across the sample, 83% reported discrimination in one or more areas of life; this was similar across WHO Regions. The three most commonly endorsed items were: ‘Do people do things for you that you could do yourself because they know you have dementia?’ (52.3%), ‘Because of your dementia, have some people not taken your opinions seriously?’ (50.2%) and ‘Have you been told that you couldn't do something that you still thought you could do?’ (44.0%). The high endorsement of these items corresponds to previous findings showing that people living with dementia often experience their autonomy being restricted and personhood undervalued or dismissed.Reference Young, Lind, Orange and Savundranayagam5,Reference O'Connor, Mann and Wiersma29 This reflects previous understandings of consequences of stigma for people with dementia, including qualitative studies in LMICs from the perspective of people living with dementia and caregivers.Reference Hurzuk, Farina, Pattabiraman, Ramasamy, Alladi and Rajagopalan9Reference Jacobs, Schneider, Farina, du Toit and Evans-Lacko12

Some regional variation was seen in levels of endorsement for DISCUS-Dementia items. The qualitative work helps clarify potential reasons for this in terms of structural and cultural differences, which underpin expectations around privacy, social life and housing (e.g. policy changes that place greater emphasis on rights and protections of people living with dementia concerning housing, benefits and social participation).Reference Gove, Andrews, Capstick, Geoghegan, Georges and Libert30 This may have led to social change focused on altering disabling environments and structural changes to accommodate people living with dementia. Respondents in the Western Pacific Region reported greater experiences of discrimination in housing compared with the European Region and Region of the Americas, perhaps because of the way housing is managed in the Western Pacific Region. For example, a recent study emphasised the need to reform housing practices in China to reduce disabling people living with dementia through discrimination (infantilising), which may explain why participants from the Western Pacific Region endorsed discrimination in housing more highly than others.Reference Herat-Gunaratne, Cooper, Mukadam, Rapaport, Leverton and Higgs31,Reference Zhao, Liu, Ding and Chan32 Although culture likely contributes to regional differences,Reference Herrmann, Welter, Leverenz, Lerner, Udelson and Kanetsky8, Reference Werner and Kim33 at this stage we can only hypothesise why these differences exist.

Strengths and limitations

Recruiting a large online sample allowed us to validate the DISCUS-Dementia among a considerable sample of people living with dementia across 33 diverse countries. Data on experiences of dementia-related stigma and discrimination have never previously been collected on such a large scale. A limitation is that most participants were educated women living in high-income countries, similar to other survey-based studies. Although we worked together with local Alzheimer's associations to support people without internet access to complete the survey, vulnerable subgroups may be underrepresented; this would be important to address in future research, and for wider generalisability of findings. To the extent possible, we attempted to address non-response bias by weighting results to be representative within each country in relation to age, gender and education. Nevertheless, further work is needed to explore how the DISCUS-Dementia performs among, for example, individuals with less education and those who live in remote areas and in other geographic settings, particularly low-income countries. We did attempt to include participants without internet access, and our sample did include participants who only completed primary school education or less (5%) and who lived in rural (9%) or semi-rural (23%) areas. Nonetheless, such underrepresented groups should be a focus of future research as they are likely further disadvantaged in a range of other areas (poverty, ableism); for example, by feeling less entitled to receive adequate care or having lower expectations about social interactions.

Another limitation is that we did not have a formal measure of dementia severity. As dementia is a heterogeneous condition with varied symptoms and stages, these differences may influence individuals’ experiences and perceptions of discrimination. Moreover, people living with dementia in LMICs tend to receive a diagnosis late in the course of illness and so are more likely to have severe symptoms once diagnosed, posing additional barriers to survey participation. We relied on participant self-report, which may introduce some error or uncertainty in identification of participants. We also conducted a sensitivity analysis to consider those who used proxy support to complete the survey. We argue that it is important to give people with dementia a voice and an opportunity to express their views and feelings. The DISCUS-Dementia is designed to capture the self-reported experiences of discrimination by people with dementia, regardless of their cognitive status, and does not rely on specific episodic memory or factual recall. Future work should explore ways in which the DISCUS-Dementia can be used to quantify experiences of people living with advanced dementia, with careful thought to data collection methodology and accommodations for participants with varying levels of symptom severity.

Research and practice implications

The DISCUS-Dementia is a reliable, valid and acceptable measure for assessing experiences of stigma and discrimination among people living with dementia. This scale can be integrated into large-scale studies to understand prevalence of stigma and discrimination experienced by people living with dementia, including how to reduce the effects of stigma and discrimination among people living with dementia, their caregivers and families.

It is beyond the scope of our study to present an in-depth ethnographic perspective on the way cultural differences in experience of stigma and discrimination may underpin findings. However, our qualitative and quantitative findings provide a basis for hypothesis generation, and future work may look to address this pertinent question. Finally, this measure also has clinical relevance. Given that the emphasis in clinical settings is often on cognitive symptoms, an instrument such as this could provide an opportunity for a structured discussion around stigma and discrimination experiences important to people living with dementia, as well as planning psychosocial services and initiatives to reduce stigma and discrimination.

Supplementary material

Supplementary material is available online at https://doi.org/10.1192/bjo.2023.551

Data availability

The data that support the findings of this study are available from Alzheimer's Disease International. Restrictions apply to the availability of these data, which were used under licence for this study. Data are available from corresponding author, S.E.-L., with the permission of Alzheimer's Disease International.

Acknowledgements

For the purpose of open access, the author has applied a Creative Commons Attribution (CC BY) licence (where permitted by UKRI, ‘Open Government Licence’ or ‘Creative Commons Attribution No-derivatives (CC BY-ND) licence’ may be stated instead) to any author accepted manuscript version arising. We would like to thank Norman Sartorius for feedback on the adaptation process.

Author contributions

J.B. and S.E.-L. led the study at all stages and drafted the manuscript. J.B., E.B., D.B., D.O., L.H.Y. and S.E.-L. developed the analysis strategy and completed the analyses. J.B., I.B., A.C.-H., F.D., N.F., M.S., E.W., M.S.-K. and S.E.-L. developed the survey, collected data and supported the literature review. M.K. and G.T. advised on issues relevant to dementia and stigma, and supported the literature review and process of revising the DISCUS measure. All authors helped interpret the analyses, critically reviewed and revised the report for intellectual content and approved the final version for publication.

Funding

The survey was commissioned and partly funded by Alzheimer's Disease International. S.E.-L., D.O., A.C.-H., M.K., M.S. and M.S.-K. are also funded by the Strengthening responses to dementia in developing countries (STRiDE) project, which is funded by the UK Research and Innovation's Global Challenges Research Fund via the Economic and Social Research Council (grant number ES/P010938/1). S.E.-L. is also supported by the UK Medical Research Council and UK Economic and Social Research Council. D.B. was supported in part by funds from the National Human Genome Research Institute, University of Michigan Training Program in ELSI Research (grant number T32 HG010030). G.T. and I.B. are supported by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration South London at King's College Hospital NHS Foundation Trust. I.B. is partially supported by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London (grant number NIHR203318). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. G.T., S.E.-L. and I.B. are also supported by the UK Medical Research Council for the Indigo Partnership (grant number MR/R023697/1) awards.

Declaration of interest

S.E.-L. is a member of the BJPsych Open Editorial Board and did not take part in the review or decision-making process of this paper. All other authors declare no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

References

Nichols, E, Steinmetz, JD, Vollset, SE, Fukutaki, K, Chalek, J, Abd-Allah, F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022; 7: e105–25.CrossRefGoogle Scholar
Wimo, A, Seeher, K, Cataldi, R, Cyhlarova, E, Dielemann, J, Frisell, O, et al. The worldwide costs of dementia in 2019. Alzheimers Dement 2023; 19(7): 2865–73.CrossRefGoogle ScholarPubMed
Alzheimer's Disease International. World Alzheimer Report 2019: Attitudes to Dementia. Alzheimer's Disease International, 2019 (https://www.alzint.org/resource/world-alzheimer-report-2019/).Google Scholar
Thornicroft, G, Sunkel, C, Alikhon Aliev, A, Baker, S, Brohan, E, el Chammay, R, et al. The Lancet Commission on ending stigma and discrimination in mental health. Lancet 2022; 400: 1438–80.CrossRefGoogle ScholarPubMed
Young, JA, Lind, C, Orange, JB, Savundranayagam, MY. Expanding current understandings of epistemic injustice and dementia: learning from stigma theory. J Aging Stud 2019; 48: 7684.CrossRefGoogle ScholarPubMed
Nguyen, T, Li, X. Understanding public-stigma and self-stigma in the context of dementia: a systematic review of the global literature. Dementia (London) 2020; 19(2): 148–81.CrossRefGoogle ScholarPubMed
World Health Organization (WHO). Global Status Report on the Public Health Response to Dementia. WHO, 2021 (https://www.who.int/publications/i/item/9789240033245).Google Scholar
Herrmann, LK, Welter, E, Leverenz, J, Lerner, AJ, Udelson, N, Kanetsky, C, et al. A systematic review of dementia-related stigma research: can we move the stigma dial? Am J Geriatr Psychiatry 2018; 26: 316–31.CrossRefGoogle ScholarPubMed
Hurzuk, S, Farina, N, Pattabiraman, M, Ramasamy, N, Alladi, S, Rajagopalan, J, et al. Understanding, experiences and attitudes of dementia in India: a qualitative study. Dementia (London) 2022; 21(7): 2288–306.CrossRefGoogle ScholarPubMed
Oliveira, D, Da Mata, FAF, Mateus, E, Musyimi, CW, Farina, N, Ferri, CP, et al. Experiences of stigma and discrimination among people living with dementia and family carers in Brazil: qualitative study. Ageing Soc 2023; 43(2): 447–68.CrossRefGoogle Scholar
Musyimi, CW, Ndetei, DM, Evans-Lacko, S, Oliveira, D, Mutunga, E, Farina, N. Perceptions and experiences of dementia and its care in rural Kenya. Dementia (London) 2021; 20: 2802–19.CrossRefGoogle ScholarPubMed
Jacobs, R, Schneider, M, Farina, N, du Toit, P, Evans-Lacko, S. Stigma and its implications for dementia in South Africa: a multi-stakeholder exploratory study. Ageing Soc [Epub ahead of print] 9 Jun 2022. Available from: https://doi.org/10.1017/S0144686X2200040X.CrossRefGoogle Scholar
Burgener, SC, Berger, B. Measuring perceived stigma in persons with progressive neurological disease: Alzheimer's dementia and Parkinson's disease. Dementia (London) 2008; 7: 3153.CrossRefGoogle Scholar
Burgener, SC, Buckwalter, K, Perkhounkova, Y, Liu, MF. The effects of perceived stigma on quality of life outcomes in persons with early-stage dementia: longitudinal findings: part 2. Dementia (London) 2015; 14: 609–32.CrossRefGoogle ScholarPubMed
Thornicroft, G, Brohan, E, Rose, D, Sartorius, N, Leese, M. Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet 2009; 373: 408–15.CrossRefGoogle ScholarPubMed
Brohan, E, Thornicroft, G, Rüsch, N, Lasalvia, A, Campbell, MM, Yalçlnkaya-Alkar, Ö, et al. Measuring discrimination experienced by people with a mental illness: replication of the short-form DISCUS in six world regions. Psychol Med 2022; 53(9): 111.Google ScholarPubMed
World Health Organization (WHO). Process of Translation and Adaptation of Instruments. WHO, 2016 (https://www.mhinnovation.net/sites/default/files/files/WHO Guidelines on Translation and Adaptation of Instruments.docx).Google Scholar
Tennant, R, Hiller, L, Fishwick, R, Platt, S, Joseph, S, Weich, S, et al. The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes 2007; 5: 63.CrossRefGoogle ScholarPubMed
Clarke, C, Woods, B, Moniz-Cook, E, Mountain, G, Øksnebjerg, L, Chattat, R, et al. Measuring the well-being of people with dementia: a conceptual scoping review. Health Qual Life Outcomes 2020; 18: 249.CrossRefGoogle ScholarPubMed
Marmara, J, Zarate, D, Vassallo, J, Patten, R, Stavropoulos, V. Warwick-Edinburgh Mental Well-Being Scale (WEMWBS): measurement invariance across genders and item response theory examination. BMC Psychol 2022; 10: 31.CrossRefGoogle ScholarPubMed
Brod, M, Stewart, AL, Sands, L, Walton, P. Conceptualization and measurement of quality of life in dementia: the Dementia Quality of Life instrument (DQoL). Gerontologist 1999; 39: 2535.CrossRefGoogle ScholarPubMed
Lion, KM, Szcześniak, D, Bulińska, K, Evans, SB, Evans, SC, Saibene, FL, et al. Do people with dementia and mild cognitive impairments experience stigma? A cross-cultural investigation between Italy, Poland and the UK. Aging Ment Health 2020; 24(6): 947–55.CrossRefGoogle ScholarPubMed
Bhatt, J, Stoner, CR, Scior, K, Charlesworth, G. Adaptation and preliminary psychometric properties of three self-stigma outcome measures for people living with dementia. BMC Geriatr 2021; 21: 34.CrossRefGoogle ScholarPubMed
Bakolis, I, Thornicroft, G, Vitoratou, S, Rüsch, N, Bonetto, C, Lasalvia, A, et al. Development and validation of the DISCUS scale: a reliable short measure for assessing experienced discrimination in people with mental health problems on a global level. Schizophr Res 2019; 212: 213–20.CrossRefGoogle Scholar
Cappelleri, JC, Zou, KH, Bushmakin, AG, Alvir, JMJ, Alemayehu, D, Symonds, T. Patient-Reported Outcomes: Measurement, Implementation and Interpretation. CRC Press, 2013.CrossRefGoogle Scholar
Cohen, J. Statistical Power Analysis for the Behavioral Sciences. Routledge, 2013.CrossRefGoogle Scholar
World Health Organization (WHO). A Blueprint for Dementia Research. WHO, 2022 (https://www.who.int/publications/i/item/9789240058248).Google Scholar
Yang, LH, Thornicroft, G, Alvarado, R, Vega, E, Link, BG. Recent advances in cross-cultural measurement in psychiatric epidemiology: utilizing ‘what matters most’ to identify culture-specific aspects of stigma. Int J Epidemiol 2014; 43: 494510.CrossRefGoogle ScholarPubMed
O'Connor, D, Mann, J, Wiersma, E. Stigma, discrimination and agency: diagnostic disclosure as an everyday practice shaping social citizenship. J Aging Stud 2018; 44: 4551.CrossRefGoogle ScholarPubMed
Gove, DM, Andrews, J, Capstick, A, Geoghegan, C, Georges, J, Libert, S, et al. Dementia as a Disability? Implications for Ethics, Policy and Practice. Alzheimer Europe, 2019 (https://www.alzheimer-europe.org/sites/default/files/alzheimer_europe_ethics_report_2017.pdf).Google Scholar
Herat-Gunaratne, R, Cooper, C, Mukadam, N, Rapaport, P, Leverton, M, Higgs, P, et al. ‘In the Bengali vocabulary, there is no such word as care home’: caring experiences of UK Bangladeshi and Indian family carers of people living with dementia at home. Gerontologist 2020; 60: 331–9.Google ScholarPubMed
Zhao, Y, Liu, L, Ding, Y, Chan, HYL. Understanding dementia care in care home setting in China: an exploratory qualitative study. Health Soc Care Community 2021; 29: 1511–21.CrossRefGoogle Scholar
Werner, P, Kim, S. A cross-national study of dementia stigma among the general public in Israel and Australia. J Alzheimers Dis 2021; 83: 103–10.CrossRefGoogle ScholarPubMed
Figure 0

Table 1 DISCUS-Dementia face validity and exemplar quotes

Figure 1

Table 2 Exploratory factor analysis

Figure 2

Table 3 Summary of psychometric properties of the DISCUS-Dementia by region

Figure 3

Table 4 Endorsement of unfair treatment among people living with dementia overall and by region

Supplementary material: File

Bhatt et al. supplementary material
Download undefined(File)
File 43 KB
Submit a response

eLetters

No eLetters have been published for this article.